Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Clinical trial NCT02728531 · COMPLETED

Trial details

NCT number: NCT02728531
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2016-04-18
Primary completion: 2019-01-16
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.